Chen YY - Search Results

1

Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of Resistance.

Chang YS, Su CW, Chen SC, Chen YY, Liang YJ, Wu JC. Chang YS, et al. Among authors: chen sc, chen yy. Cells. 2022 Feb 11;11(4):634. doi: 10.3390/cells11040634. Cells. 2022. PMID: 35203285 Free PMC article.

2

Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation.

Liang YJ, Kuo HH, Lin CH, Chen YY, Yang BC, Cheng YY, Yu AL, Khoo KH, Yu J. Liang YJ, et al. Among authors: chen yy. Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22564-9. doi: 10.1073/pnas.1007290108. Epub 2010 Dec 13. Proc Natl Acad Sci U S A. 2010. PMID: 21149694 Free PMC article.

3

Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.

Chi CT, Chau GY, Lee RC, Chen YY, Lei HJ, Hou MC, Chao Y, Huang YH. Chi CT, et al. Among authors: chen yy. J Formos Med Assoc. 2020 Jan;119(1 Pt 1):125-133. doi: 10.1016/j.jfma.2019.02.012. Epub 2019 Mar 12. J Formos Med Assoc. 2020. PMID: 30876788 Free article.

4

Upregulation of miR-125b, miR-181d, and miR-221 Predicts Poor Prognosis in MGMT Promoter-Unmethylated Glioblastoma Patients.

Chen YY, Ho HL, Lin SC, Ho TD, Hsu CY. Chen YY, et al. Am J Clin Pathol. 2018 Mar 29;149(5):412-417. doi: 10.1093/ajcp/aqy008. Am J Clin Pathol. 2018. PMID: 29538610

5

Loss of BCAT1 Expression is a Sensitive Marker for IDH-Mutant Diffuse Glioma.

Chen YY, Ho HL, Lin SC, Hsu CY, Ho DM. Chen YY, et al. Neurosurgery. 2019 Sep 1;85(3):335-342. doi: 10.1093/neuros/nyy338. Neurosurgery. 2019. PMID: 30113684

6

Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol.

Ioannou GN, Lee SP, Linsley PS, Gersuk V, Yeh MM, Chen YY, Peng YJ, Dutta M, Mascarinas G, Molla B, Cui JY, Savard C. Ioannou GN, et al. Among authors: chen yy. Hepatol Commun. 2022 Apr;6(4):780-794. doi: 10.1002/hep4.1858. Epub 2021 Nov 24. Hepatol Commun. 2022. PMID: 34816633 Free PMC article.

7

The impact of modified staining method on HER2 immunohistochemical staining for HER2-low breast cancer.

Chen YY, Yang CF, Hsu CY. Chen YY, et al. Pathology. 2024 Feb;56(1):122-124. doi: 10.1016/j.pathol.2023.06.002. Epub 2023 Aug 12. Pathology. 2024. PMID: 37657990 No abstract available.

8

Adjust cut-off values of immunohistochemistry models to predict risk of distant recurrence in invasive breast carcinoma patients.

Chen YY, Tseng LM, Yang CF, Lien PJ, Hsu CY. Chen YY, et al. J Chin Med Assoc. 2016 Dec;79(12):649-655. doi: 10.1016/j.jcma.2016.06.004. Epub 2016 Aug 29. J Chin Med Assoc. 2016. PMID: 27595437 Free article.

9

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation.

Chen YY, Yeh MM. Chen YY, et al. J Formos Med Assoc. 2021 Jan;120(1 Pt 1):68-77. doi: 10.1016/j.jfma.2020.07.006. Epub 2020 Jul 9. J Formos Med Assoc. 2021. PMID: 32654868 Free article. Review.

10

A Rare Cause of a Liver Tumor Nodule.

Chau IY, Chen YY, Chau GY. Chau IY, et al. Among authors: chen yy. Gastroenterology. 2021 Feb;160(3):663-665. doi: 10.1053/j.gastro.2020.10.005. Epub 2020 Oct 8. Gastroenterology. 2021. PMID: 33039472 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,320 results

Search Page

Filters